Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Solana achieves record $147B in perps trading volume in Q2 2026

Solana achieves record $147B in perps trading volume in Q2 2026

CryptobriefingCryptobriefing2026/07/02 10:12
By:Cryptobriefing

Solana’s perpetual futures trading volume hit $147 billion in the second quarter of 2026, a record for the network. The Q2 figure contributes to a staggering $255.6 billion in total perps volume across Solana venues during the first half of 2026. That represents a 57.1% increase year-over-year, compared to Hyperliquid’s 6.4% expansion over the same period.

The protocols driving the surge

Two names keep showing up when you trace the volume: Drift Protocol and Jupiter Perps.

Advertisement
window.sevioads = window.sevioads || []; var sevioads_preferences = []; sevioads_preferences[0] = {}; sevioads_preferences[0].zone = "de1434f5-fa9e-44a6-93c3-4c2439763717"; sevioads_preferences[0].adType = "banner"; sevioads_preferences[0].inventoryId = "c5700508-581b-472c-8fdd-a931cdbfc8e1"; sevioads_preferences[0].accountId = "1e47efc1-ec2d-4fca-a8b9-354e249e5095"; sevioads.push(sevioads_preferences);

Drift operates a hybrid model combining a central limit order book (CLOB) with a virtual automated market maker (vAMM), blending the precision of traditional exchange-style order matching with the always-on liquidity that DeFi is known for.

Jupiter Perps, built on top of Solana’s largest aggregator, benefits from the massive existing user base that already routes swaps through Jupiter’s interface.

Solayer launched its Margin Trade mainnet on June 3, 2026, opening up perpetual futures for crypto, commodities, and equity-index contracts.

The broader Solana ecosystem context

Solana’s stablecoin supply reached an all-time high of $16.6 billion in Q2 2026. Tokenized equities tell a similar story: Solana handled $4.9 billion in tokenized stock volume during H1 2026, a sixfold increase from the second half of 2025. Over 95% of all cross-chain tokenized equity volume now runs through Solana.

What this means for investors

Drift, Jupiter, and Solayer all generate fee revenue from the volume flowing through their platforms. Hyperliquid, which built its entire identity around being the go-to chain for perps, grew just 6.4% year-over-year compared to Solana’s 57.1%.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "Outlier" Investment Art in the New Era of Berky

他山之石观投资2026/09/14 09:22
The "Outlier" Investment Art in the New Era of Berky

Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.

智通财经2026/09/14 09:12
Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

智通财经2026/09/14 08:57
Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales

Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.

智通财经2026/09/14 08:41
AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales